UBS Maintains Neutral on Cabot, Raises Price Target to $103
Portfolio Pulse from Benzinga Newsdesk
UBS analyst Joshua Spector maintains a Neutral rating on Cabot (NYSE:CBT) and raises the price target from $100 to $103.

May 07, 2024 | 3:51 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
UBS maintains a Neutral rating on Cabot and raises the price target from $100 to $103.
The increase in price target by UBS suggests a positive outlook on Cabot's financial performance and potential for growth, likely leading to a short-term positive impact on the stock price. The Neutral rating indicates that while there may not be significant upside, the stock is expected to perform steadily.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 90